drugset
drugset / Trial / NCT03247283

Pharmacokinetics and Metabolism Study in Healthy Male Participants

NCT03247283 ↗

Phase 1 Completed 9 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelHealth-services research

Summary

Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males

Timeline

Start
2017-07-19
Primary completion
2017-10-15
Completion
2017-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject LINRODOSTAT Small molecule — Oral

Indications

cancer